MAM
Indians’ paradox on Human Rights – Espouse benefits for a just society; warn of misuse by wrong elements: Ipsos Survey
MUMBAI: According to a new survey by Ipsos on Human Rights, Indians are aware about the broad contours of Human Rights with the majority of them advocating the merits of them for a better living.
The survey shows that at least 69% Indians claim to be aware of Human Rights and view it in positive light in different ways: 8 in 10 Indians support a law on Human Rights (78%); 71% believe strongly in Human Rights, 69% believe that the law makes life positive and 74% believe it creates a fairer society. At the same time, the majority warns and believes people take unfair advantage of Human Rights (67%) and a significant number of Indians believe those benefitting from Human Rights are the undeserving – the criminals and terrorists (53%).
“The Law on Human Rights empowers the society, mitigating risks of injustice. Human Rights is protective and ensures fair treatment,” says Parijat Chakraborty, executive director, Ipsos Public Affairs.
Interestingly, from the United Nations’ Declaration of Human Rights and the fundamental rights that need to be protected, out of the total of 30 different rights, the top ones chosen by Indians were Freedom of Speech (39%), Right to Vote (31%), Right to Privacy (30%), Right to Security/ to be Safe (27%), Right to equal treatment before the law (25%), Right of children to free education (25%), Freedom of thought and religion (24%), Freedom from discrimination (such as race, colour, gender, language, religion, disability, national or social origin, or any status) (22%), Right to work, and to equal work for equal pay (22%), Right to free or low cost, healthcare (19%), Right to freedom from slavery or forced labour (16%) among others.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
